Purchase Order 36C25926P0226
- Not listed
- INO Therapeutics LLC, a Missouri-based supplier of inhaled nitric oxide therapeutic gases and respiratory therapy systems, was awarded a delivery order valued at $51,982.38 by Veterans Integrated Service Network 22, a civilian component of the Department of Veterans Affairs. The contract, issued March 1, 2024, with an ultimate completion date of February 28, 2025, operates under a firm fixed-price structure and is classified as a non-set-aside award. Performance will be executed at the...
- The Department of Veterans Affairs, through Veterans Integrated Service Network 17, awarded a delivery order valued at $145,785.00 to INO Therapeutics LLC for nitric oxide inhalation therapy services. This firm fixed-price contract, issued without a set-aside designation, is scheduled for completion by February 4, 2030, and will be performed in San Antonio, Texas. The delivery order is issued under the parent Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB), leveraging existing...
- This is a federal contract award made by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs (VA) to INO Therapeutics LLC, a for-profit company that provides inhaled nitric oxide therapy systems and related medical gases. The contract, valued at $323,299.11, is a delivery order under the VA's Pharmaceuticals and Drugs GSA Schedule. It is for the supply of nitric oxide gas to support respiratory treatments and related healthcare programs for veterans...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs to INO Therapeutics LLC, a company that provides inhaled nitric oxide to improve oxygenation in term and near term neonates. The contract, worth $86,851.51, is for the supply of nitric oxide gas. It is not a set-aside contract. INO Therapeutics has been awarded over 50 federal contracts since 2002 to provide inhaled nitric oxide gas, nitrous oxide gas, INOmax therapy, and INOtherapy services to VA hospitals...
- INO Therapeutics LLC, a Missouri-based supplier of inhaled nitric oxide therapeutic solutions, was awarded a contract valued at $66,029.21 by the Department of Veterans Affairs' Veterans Integrated Service Network 22 (VISN 22) for inhalation therapy services supporting Veterans Administration medical facilities in California. The contract, awarded June 1, 2021, was issued as a call against an existing Blanket Purchase Agreement (BPA) under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB)...
- This is a $127,935.83 firm fixed price delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration to INO Therapeutics LLC, a foreign-owned for-profit company, to provide inhaled nitric oxide gases. The contract is issued under the Pharmaceuticals and Drugs GSA Schedule and does not have a set-aside designation. INO Therapeutics has been awarded over 50 similar federal contracts since 2002 to supply inhaled nitric oxide therapy systems and related medical...
- INO Therapeutics LLC, a Missouri-based supplier of inhaled nitric oxide (INO) therapeutic solutions, received a delivery order valued at $53,381.63 from Veterans Integrated Service Network 19 (VISN 19) for the provision of inotherapy nitric oxide gas therapy and related services. Issued as a firm fixed-price contract on May 27, 2021, with an ultimate completion date of May 26, 2026, this non-set-aside delivery order will be performed in Hazelwood, Missouri. The contract represents a continuation...
- INO Therapeutics LLC, a Hazelwood, Missouri-based supplier of inhaled nitric oxide (INO) therapeutic gases and related medical services, was awarded a $321,643 firm fixed-price delivery order by Veterans Integrated Service Network 10 on April 27, 2022. This non-set-aside contract, with an ultimate completion date of April 26, 2027, falls under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB) and represents a task order issued against a larger Indefinite Delivery/Indefinite...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 16 to INO Therapeutics LLC, a for-profit company that specializes in providing inhaled nitric oxide therapy systems and related medical gases to government agencies. The $16,458.08 contract is for the delivery of inotherapy services, with a period of performance ending on August 28, 2020. INO Therapeutics has been awarded over 50 federal contracts since 2002 to...
- This is a federal contract award to INO Therapeutics LLC, a foreign-owned, for-profit company, to provide Nitric Therapy with Nitric Oxide. The contract was awarded by the Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 17. The contract is a Delivery Order under the Pharmaceuticals and Drugs (FSS-61-IB) General Services Administration (GSA) Schedule, with a firm fixed price of $156,996.47. The contract is for the delivery of inhaled nitric oxide...
The Department of Veterans Affairs' Veterans Integrated Service Network 19 awarded a $53,970 firm fixed-price purchase order to INO Therapeutics LLC on May 27, 2026, for the supply of inhaled nitric oxide (INO) therapy services. This contract, which extends through December 31, 2030, was awarded as a sole-source procurement under FAR 8.405-6(a)(2) to support the Rocky Mountain Regional VA Medical Center's critical care operations. INO Therapeutics, a large business headquartered in Hazelwood, Missouri, specializes in providing therapeutic nitric oxide gases and inhalation therapy systems to federal healthcare agencies. The contract will supply inhaled nitric oxide to treat conditions such as pulmonary hypertension and acute respiratory distress syndrome in critically ill veteran patients. No small business set-aside designation was applied to this award. This purchase order represents a child contract under INO Therapeutics' existing blanket purchase agreement with VISN 2, one of three active BPAs the company maintains with the VA and Defense Health Agency. The company has demonstrated substantial federal contracting experience across multiple Veterans Integrated Service Networks and military medical centers nationwide, with prior contract values ranging from approximately $485 to over $900,000. The indefinite delivery/indefinite quantity structure of the parent BPA framework has enabled the VA to procure specialized medical gases and respiratory therapy services on an as-needed basis to support the federal government's requirement for continuous, reliable supply of critical therapeutic gases across the veteran healthcare system.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--36C25926Q0207| Intent to Sole Source on INOtherapy for Rocky Mountain Regional VA Medical Center | 36C25926Q0207 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 | Special Notice 1/1 | 1/26/26, 1:35 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 2/3/26 |